Lineage Cell Therapeutics
LCTX
#8906
Rank
ยฃ0.14 B
Marketcap
ยฃ0.59
Share price
-5.87%
Change (1 day)
-55.60%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -ยฃ20.15 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ13.08 Million. In 2025 the company made an earning of -ยฃ16.65 Million a decrease over its 2024 earnings that were of -ยฃ16.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ20.15 Million21.01%
2025 -ยฃ16.65 Million1.4%
2024 -ยฃ16.42 Million-13.16%
2023 -ยฃ18.91 Million9.83%
2022 -ยฃ17.22 Million-54.24%
2021 -ยฃ37.62 Million86.07%
2020 -ยฃ20.22 Million-31.97%
2019 -ยฃ29.72 Million-5.42%
2018 -ยฃ31.42 Million1.1%
2017 -ยฃ31.08 Million-31.06%
2016 -ยฃ45.08 Million-10.38%
2015 -ยฃ50.31 Million29.69%
2014 -ยฃ38.79 Million31.68%
2013 -ยฃ29.46 Million
2011 -ยฃ14.3 Million89.78%
2010 -ยฃ7.54 Million206.06%
2009 -ยฃ2.47 Million-0.58%
2008 -ยฃ2.48 Million164.89%
2007 -ยฃ0.94 Million-30.22%
2006 -ยฃ1.34 Million
2002 -ยฃ1.56 Million-41.04%
2001 -ยฃ2.64 Million-32.04%
2000 -ยฃ3.89 Million-11.85%
1999 -ยฃ4.41 Million
1997 -ยฃ2.83 Million12.12%
1996 -ยฃ2.53 Million106.25%
1995 -ยฃ1.23 Million-11.11%
1994 -ยฃ1.38 Million50%
1993 -ยฃ0.92 Million20%
1992 -ยฃ0.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 481.52%๐Ÿ‡บ๐Ÿ‡ธ USA